Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Prospective, Multicentre, National Trial on the Benefit of Botulinum Toxin Type A (BoNT-A) Injections in Untreated Chronic Post-stroke Spastic Brazilian Patients

NCT02390206 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02390206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02390206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Prospective, Multicentre, National Trial on the Benefit of Botulinum Toxin Type A (BoNT-A) Injections in Untreated Chronic Post-stroke Spastic Brazilian Patients
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
August 28, 2017
Enrollment
239 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

spasticity